Cargando…

Surgical indications and clinical management of benign and malignant follicular thyroid tumors: An algorithmic-based approach

The present study retrospectively reviewed the treatment courses and results of patients with follicular thyroid tumors, including carcinomas. In the 5 year study period from April 2015 to March 2020, 797 patients with differentiated thyroid carcinoma and 128 patients with follicular tumors (FTs) re...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwasaki, Hiroyuki, Toda, Soji, Murayama, Daisuke, Kato, Shin, Matsui, Ai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783721/
https://www.ncbi.nlm.nih.gov/pubmed/33414913
http://dx.doi.org/10.3892/mco.2020.2194
_version_ 1783632166488375296
author Iwasaki, Hiroyuki
Toda, Soji
Murayama, Daisuke
Kato, Shin
Matsui, Ai
author_facet Iwasaki, Hiroyuki
Toda, Soji
Murayama, Daisuke
Kato, Shin
Matsui, Ai
author_sort Iwasaki, Hiroyuki
collection PubMed
description The present study retrospectively reviewed the treatment courses and results of patients with follicular thyroid tumors, including carcinomas. In the 5 year study period from April 2015 to March 2020, 797 patients with differentiated thyroid carcinoma and 128 patients with follicular tumors (FTs) received surgery or treatment for distant metastases and recurrence at the Kanagawa Cancer Center (Japan). Of these patients, 73 that were diagnosed with follicular thyroid carcinoma (FTC) were included in the present study. An algorithm used for the application of treatment strategies was assessed. The aim of the present study was to examine patients with FT or FTC who were treated at the Kanagawa Cancer Center to devise appropriate treatment strategies and to evaluate the various treatment outcomes of FTC. Pre-diagnostic serum thyroglobulin and thyroid stimulating hormone levels, follow-up and overall survival (OS) were investigated in the present study. The results revealed that OS was significantly increased in patients with minimally invasive follicular thyroid cancer (MIFTC) compared with widely invasive follicular thyroid cancer (WIFTC) (log-rank test, P=0.017). Additionally, OS was significantly higher in patients without distant metastasis at the first consultation compared with those initially diagnosed with distant metastasis (log-rank test, P=0.023). Although all patients without distant metastasis at the first consultation and those with MIFTC are alive, the 10-year survival rates were 75.3% for patients with WIFTC and 75.6% for those with distant metastasis at the first consultation. The results of the present study suggested that the prognosis of WIFTC was the worst among patients with FTC and distant metastasis, and that total thyroidectomy surgery and radioactive iodine treatment are essential. Additionally, if the disease progresses, prompt inclusion of tyrosine kinase inhibitor therapy is necessary.
format Online
Article
Text
id pubmed-7783721
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-77837212021-01-06 Surgical indications and clinical management of benign and malignant follicular thyroid tumors: An algorithmic-based approach Iwasaki, Hiroyuki Toda, Soji Murayama, Daisuke Kato, Shin Matsui, Ai Mol Clin Oncol Articles The present study retrospectively reviewed the treatment courses and results of patients with follicular thyroid tumors, including carcinomas. In the 5 year study period from April 2015 to March 2020, 797 patients with differentiated thyroid carcinoma and 128 patients with follicular tumors (FTs) received surgery or treatment for distant metastases and recurrence at the Kanagawa Cancer Center (Japan). Of these patients, 73 that were diagnosed with follicular thyroid carcinoma (FTC) were included in the present study. An algorithm used for the application of treatment strategies was assessed. The aim of the present study was to examine patients with FT or FTC who were treated at the Kanagawa Cancer Center to devise appropriate treatment strategies and to evaluate the various treatment outcomes of FTC. Pre-diagnostic serum thyroglobulin and thyroid stimulating hormone levels, follow-up and overall survival (OS) were investigated in the present study. The results revealed that OS was significantly increased in patients with minimally invasive follicular thyroid cancer (MIFTC) compared with widely invasive follicular thyroid cancer (WIFTC) (log-rank test, P=0.017). Additionally, OS was significantly higher in patients without distant metastasis at the first consultation compared with those initially diagnosed with distant metastasis (log-rank test, P=0.023). Although all patients without distant metastasis at the first consultation and those with MIFTC are alive, the 10-year survival rates were 75.3% for patients with WIFTC and 75.6% for those with distant metastasis at the first consultation. The results of the present study suggested that the prognosis of WIFTC was the worst among patients with FTC and distant metastasis, and that total thyroidectomy surgery and radioactive iodine treatment are essential. Additionally, if the disease progresses, prompt inclusion of tyrosine kinase inhibitor therapy is necessary. D.A. Spandidos 2021-02 2020-12-17 /pmc/articles/PMC7783721/ /pubmed/33414913 http://dx.doi.org/10.3892/mco.2020.2194 Text en Copyright: © Iwasaki et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Iwasaki, Hiroyuki
Toda, Soji
Murayama, Daisuke
Kato, Shin
Matsui, Ai
Surgical indications and clinical management of benign and malignant follicular thyroid tumors: An algorithmic-based approach
title Surgical indications and clinical management of benign and malignant follicular thyroid tumors: An algorithmic-based approach
title_full Surgical indications and clinical management of benign and malignant follicular thyroid tumors: An algorithmic-based approach
title_fullStr Surgical indications and clinical management of benign and malignant follicular thyroid tumors: An algorithmic-based approach
title_full_unstemmed Surgical indications and clinical management of benign and malignant follicular thyroid tumors: An algorithmic-based approach
title_short Surgical indications and clinical management of benign and malignant follicular thyroid tumors: An algorithmic-based approach
title_sort surgical indications and clinical management of benign and malignant follicular thyroid tumors: an algorithmic-based approach
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783721/
https://www.ncbi.nlm.nih.gov/pubmed/33414913
http://dx.doi.org/10.3892/mco.2020.2194
work_keys_str_mv AT iwasakihiroyuki surgicalindicationsandclinicalmanagementofbenignandmalignantfollicularthyroidtumorsanalgorithmicbasedapproach
AT todasoji surgicalindicationsandclinicalmanagementofbenignandmalignantfollicularthyroidtumorsanalgorithmicbasedapproach
AT murayamadaisuke surgicalindicationsandclinicalmanagementofbenignandmalignantfollicularthyroidtumorsanalgorithmicbasedapproach
AT katoshin surgicalindicationsandclinicalmanagementofbenignandmalignantfollicularthyroidtumorsanalgorithmicbasedapproach
AT matsuiai surgicalindicationsandclinicalmanagementofbenignandmalignantfollicularthyroidtumorsanalgorithmicbasedapproach